Terminated PHASE4 INTERVENTIONAL 2-arm NCT01005849

Probiotics and the Prevention of Traveler's Diarrhea (TD)

A Parallel, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy of Probiotic Formula in the Prevention of Traveler's Diarrhea

Sponsor: Lallemand SAS

Conditions Travelers' Diarrhea

Interventions Placebo Protecflor

Updated 5 times since 2017 Last updated: Jan 18, 2012 Started: Oct 31, 2009 Primary completion: Sep 30, 2011 Completion: Sep 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

because of low rate recruitment and the inability to reach the target expected

Other Travelers' Diarrhea trials with similar outcome

NCT02920242 · Phase PHASE3 · May 2017

Browse all Travelers' Diarrhea trials

This PHASE4 trial investigates Travelers' Diarrhea and is currently terminated or withdrawn. Lallemand SAS leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lallemand SAS
Sprim Advanced Life Sciences

Data source: Lallemand SAS

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Milan, Italy